US Patent 8192741 Method of treating rheumatoid arthritis with an anti-IL-6R antibody
Patent 8192741 was granted and assigned to Regeneron Pharmaceuticals, Inc. on June, 2012 by the United States Patent and Trademark Office.
All edits
Edits on 4 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 22 Feb, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 29 Nov, 2023
Golden AI
Edits made to:
Article (+586 characters)
Article
Patent abstract
The present invention provides methods of preventing or treating rheumatoid arthritis using a fully human antibody or antigen-binding fragment thereof that specifically binds human interleukin-6 receptor (hIL-6R). The methods of the present invention may include administration of a second therapeutic agent, such as one or more of a non-steroidal anti-inflammatory drug (NSAID), a glucocorticoid, a disease-modifying anti-rheumatic drug (DMARD), or a TNF-alpha antagonist, T-cell blocker, anti-CD20 antibody, an IL-1, JAK or IL-17 antagonist, or any combination thereof.
Edits on 21 Sep, 2023
Golden AI
Edits made to:
Infobox (+12 properties)
Infobox
Patent Inventor Names
Allen Radin0
Ashique Rafique0
Eric Smith0
Gang Chen0
James P. Fandl0
Jeanette L. Fairhurst0
Joel H. Martin0
Kevin J. Pobursky0
Margaret Karow0
Nicholas J. Papadopoulos0
Sean Stevens0
Tammy T. Huang0
Edits on 14 Jun, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08192741 Method of treating rheumatoid arthritis with an anti-IL-6R antibody US Patent 8192741 Method of treating rheumatoid arthritis with an anti-IL-6R antibody
Infobox
Patent Number
08192741
Patent Number
8192741
Edits on 14 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08192741 Method of treating rheumatoid arthritis with an anti-IL-6R antibody
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08192741
Date of patent
June 5, 2012
Patent application number
13286261
Date Filed
November 1, 2011
Patent primary examiner
Find more entities like US Patent 8192741 Method of treating rheumatoid arthritis with an anti-IL-6R antibody
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
